MCID: ACT118
MIFTS: 26

Acute Non Lymphoblastic Leukemia

Categories: Cancer diseases, Immune diseases, Rare diseases

Aliases & Classifications for Acute Non Lymphoblastic Leukemia

MalaCards integrated aliases for Acute Non Lymphoblastic Leukemia:

Name: Acute Non Lymphoblastic Leukemia 52
Leukemia, Myelocytic, Acute 71

Classifications:



External Ids:

UMLS 71 C0023467

Summaries for Acute Non Lymphoblastic Leukemia

MalaCards based summary : Acute Non Lymphoblastic Leukemia, also known as leukemia, myelocytic, acute, is related to leukemia, acute myeloid and myelodysplastic syndrome, and has symptoms including edema, chest pain and angina pectoris. An important gene associated with Acute Non Lymphoblastic Leukemia is ABCB1 (ATP Binding Cassette Subfamily B Member 1). The drugs Gemtuzumab and Antineoplastic Agents, Immunological have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and myeloid, and related phenotype is hearing/vestibular/ear.

Related Diseases for Acute Non Lymphoblastic Leukemia

Diseases related to Acute Non Lymphoblastic Leukemia via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 41, show less)
# Related Disease Score Top Affiliating Genes
1 leukemia, acute myeloid 31.9 CSF1 ABCB1
2 myelodysplastic syndrome 29.7 CSF1 ABCB1
3 neutropenia 29.5 CSF1 ABCB1
4 myeloma, multiple 29.2 CSF1 ABCB1
5 acute promyelocytic leukemia 29.1 CSF1 ABCB1
6 leukemia 10.7
7 acute leukemia 10.2
8 myeloid sarcoma 10.2
9 graft-versus-host disease 10.2
10 hepatic veno-occlusive disease 10.2
11 sarcoma 10.1
12 disseminated intravascular coagulation 10.1
13 thrombocytopenia 10.1
14 spindle cell sarcoma 10.1
15 47,xyy 10.1
16 acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) 10.1
17 chromosomal triplication 10.1
18 porphyria cutanea tarda 9.9
19 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.9
20 osteogenic sarcoma 9.9
21 polycythemia vera 9.9
22 leukemia, acute lymphoblastic 9.9
23 lymphoma 9.9
24 porphyria 9.9
25 fungal infectious disease 9.9
26 bronchiolitis 9.9
27 arthropathy 9.9
28 childhood leukemia 9.9
29 polycythemia 9.9
30 myeloid leukemia 9.9
31 exophthalmos 9.9
32 intracranial hypertension 9.9
33 alopecia 9.9
34 hypereosinophilic syndrome 9.9
35 acute graft versus host disease 9.9
36 myelodysplastic syndrome with excess blasts 9.9
37 triploidy 9.9
38 refractory anemia with excess blasts in transformation 9.9
39 refractory anemia 9.9
40 hematologic cancer 9.5 CSF1 ABCB1
41 renal cell carcinoma, nonpapillary 9.2 CSF1 ABCB1

Graphical network of the top 20 diseases related to Acute Non Lymphoblastic Leukemia:



Diseases related to Acute Non Lymphoblastic Leukemia

Symptoms & Phenotypes for Acute Non Lymphoblastic Leukemia

UMLS symptoms related to Acute Non Lymphoblastic Leukemia:


edema, chest pain, angina pectoris

MGI Mouse Phenotypes related to Acute Non Lymphoblastic Leukemia:

45 (showing 1, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 hearing/vestibular/ear MP:0005377 8.62 ABCB1 CSF1

Drugs & Therapeutics for Acute Non Lymphoblastic Leukemia

Drugs for Acute Non Lymphoblastic Leukemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 71, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Gemtuzumab Phase 4
2 Antineoplastic Agents, Immunological Phase 4
3
Methotrexate Approved Phase 3 59-05-2, 1959-05-2 126941
4
Mercaptopurine Approved Phase 3 50-44-2 667490
5
Cladribine Approved, Investigational Phase 3 4291-63-8 20279
6
Cytarabine Approved, Experimental, Investigational Phase 3 147-94-4, 65-46-3 6253
7
Posaconazole Approved, Investigational, Vet_approved Phase 3 171228-49-2 147912
8
Daunorubicin Approved Phase 3 20830-81-3 30323
9
leucovorin Approved Phase 3 58-05-9 6006 143
10
Tacrolimus Approved, Investigational Phase 3 104987-11-3 445643 439492 6473866
11
Sirolimus Approved, Investigational Phase 3 53123-88-9 5284616 6436030 46835353
12
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
13
Mitoxantrone Approved, Investigational Phase 3 65271-80-9 4212
14
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
15
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3 1177-87-3
16
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
17
Etoposide Approved Phase 3 33419-42-0 36462
18
Voriconazole Approved Phase 3 137234-62-9 71616
19
Clotrimazole Approved, Vet_approved Phase 3 23593-75-1 2812
20
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
21
Fludarabine Approved Phase 3 21679-14-1, 75607-67-9 30751
22
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
23
Vidarabine Approved, Investigational Phase 3 24356-66-9 21704 32326
24
Melphalan Approved Phase 3 148-82-3 460612 4053
25
Busulfan Approved, Investigational Phase 3 55-98-1 2478
26
Folic acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
27 Antiprotozoal Agents Phase 3
28 Antiparasitic Agents Phase 3
29 Anti-Bacterial Agents Phase 3
30 Antibiotics, Antitubercular Phase 3
31 Vitamin B Complex Phase 3
32 Folic Acid Antagonists Phase 3
33 Folate Phase 3
34 Dermatologic Agents Phase 3
35 Calcineurin Inhibitors Phase 3
36 Vitamin B9 Phase 3
37 Etoposide phosphate Phase 3
38 Gastrointestinal Agents Phase 3
39 Antineoplastic Agents, Hormonal Phase 3
40 Antiemetics Phase 3
41 glucocorticoids Phase 3
42 Tubulin Modulators Phase 3
43 Analgesics Phase 3
44 Antimitotic Agents Phase 3
45 Anti-Inflammatory Agents Phase 3
46 Antimetabolites Phase 3
47 Cytochrome P-450 Enzyme Inhibitors Phase 3
48 Anti-Infective Agents Phase 3
49 Hormones Phase 3
50 Hormone Antagonists Phase 3
51 Antifungal Agents Phase 3
52 Cytochrome P-450 CYP3A Inhibitors Phase 3
53 Immunosuppressive Agents Phase 3
54 Immunologic Factors Phase 3
55 Alkylating Agents Phase 3
56 Antiviral Agents Phase 3
57 Antirheumatic Agents Phase 3
58
Idarubicin Approved Phase 2 58957-92-9 42890
59
Clofarabine Approved, Investigational Phase 2 123318-82-1 119182
60
Mesna Approved, Investigational Phase 2 3375-50-6 598
61
rituximab Approved Phase 2 174722-31-7 10201696
62
Thiotepa Approved, Investigational Phase 2 52-24-4 5453
63
Azacitidine Approved, Investigational Phase 2 320-67-2 9444
64 2-chloro-3'-deoxyadenosine Phase 2
65
Decitabine Approved, Investigational Phase 1 2353-33-5 451668
66
Vorinostat Approved, Investigational Phase 1 149647-78-9 5311
67
9-aminocamptothecin Investigational Phase 1 91421-43-1
68 Histone Deacetylase Inhibitors Phase 1
69
Hydroxyurea Approved 127-07-1 3657
70 Liver Extracts
71
asparaginase

Interventional clinical trials:

(showing 26, show less)
# Name Status NCT ID Phase Drugs
1 A Phase IV Study of Corticosteroids As Prophylaxis for Infusion-Related Adverse Events to Mylotarg® in Patients With Acute Myelogenous Leukemia (AML) Completed NCT00304447 Phase 4 Mylotarg
2 Randomized Comparison Between Two Dose Levels of Daunorubicin and Between One Versus Two Cycles of Induction Therapy for Adult Patients With Acute Myeloid Leukemia ≤65 Years Unknown status NCT02140242 Phase 3 study part 1 - dose daunorubicin
3 A Randomized Study of Two Doses Gemtuzumab Ozogamicin vs. A Two-year Maintenance With Atra Plus Chemotherapy as Post-consolidation Treatment for Intermediate and High-risk Adult Patients With Acute Promyelocytic Leukemia (Apl) Completed NCT00962767 Phase 3 gemtuzumab ozogamicin;ATRA plus 6-MP and MTX
4 A Randomized Controlled Trial of Posaconazole (SCH 56592) vs. Standard Azole Therapy for the Prevention of Invasive Fungal Infections Among High-Risk Neutropenic Patients Completed NCT00044486 Phase 3 Posaconazole oral suspension
5 A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN #0402) Completed NCT00406393 Phase 3 Tacrolimus;Methotrexate;Sirolimus
6 A Collaborative Trial for the Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia Completed NCT00136084 Phase 3 Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone;Etoposide, Cytarabine, Gemtuzumab, L-asparaginase, Mercaptopurine, methotrexate, Mitoxantrone, Prednisone, Vincristine
7 Phase III Study of Safety, Tolerance, Efficacy, Pharmacokinetics, and Costs of Therapy With Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia Terminated NCT00152594 Phase 3 voriconazole
8 A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (BMT CTN #0901) Terminated NCT01339910 Phase 3 Fludarabine and Busulfan;Fludarabine and Melphalan;Busulfan and Fludarabine;Busulfan and Cyclophosphamide;Cyclophosphamide and Total Body Irradiation
9 Phase II Study of Cladribine, High-dose Cytarabine and Idarubicin in Patients With Relapsed Acute Myeloid Leukemia Unknown status NCT00126321 Phase 2 cladribine
10 Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission Completed NCT00186381 Phase 2
11 A Phase II, Open Label Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myelogenous Leukemia Completed NCT00042354 Phase 2 clofarabine (IV formulation)
12 Risk Adapted Treatment for Primary AML in Adults up to the Age of 60 Years. Completed NCT01716793 Phase 2 Ara-C
13 A Single Arm, Multicenter Phase II Trial of Transplants of HLA-Matched, CD34+ Enriched, T Cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With AML in First or Second Morphologic Complete Remission (BMT CTN #0303) Completed NCT00201240 Phase 2
14 Clofarabine in Combination With Cytarabine and Total Body Irradiation Followed by Allogeneic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia and Acute Non-Lymphoblastic Leukemia Completed NCT00529360 Phase 1, Phase 2 Clofarabine;Clofarabine
15 Risk Adapted Treatment for Primary AML in Adults, Based on Genetics and Minimal Residual Disease (MRD) in Patients up to the Age of 70 Years. Completed NCT01723657 Phase 2 Ara-C;G-CSF
16 Randomized Trial of Unmanipulated Versus Expanded Cord Blood Completed NCT00067002 Phase 2 Rituxan;Melphalan;Thiotepa;Fludarabine;Cyclophosphamide;Mesna
17 A Phase II Study of Maintenance With Azacitidine in MDS Patients Achieving Complete or Partial Remission (CR or PR) After Intensive Chemotherapy Terminated NCT00446303 Phase 2 Azacitidine
18 Phase II Study: HSCT Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit Terminated NCT01050946 Phase 2
19 A Phase I Clinical Trial of Vorinostat in Combination With Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome Completed NCT00479232 Phase 1 vorinostat;decitabine
20 Multicenter Study of 9-AC in Refractory Leukemia Completed NCT00251368 Phase 1 9-Aminocamptothecin (9-AC)
21 A Clinical Trial of Donor-derived WT1 Specific T Cells for Prevention of Relapse in Combination With Multiple Pathogen Specific T Cells for Prevention of Infection in Patients Undergoing Allogeneic Haemopoietic Stem Cell Transplant for AML Recruiting NCT02895412 Phase 1
22 Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes for Therapy of Relapsed Leukemia After Allogeneic Stem Cell Therapy Terminated NCT00048100 Phase 1
23 AML Treatment in Untreated Adult Patients According to EORTC-GIMEMA Protocols AML8 and AML10 Unknown status NCT00449319 Daunorubicine
24 Use of the MiCK Assay for Apoptosis to Predict Complete Remission in Acute Myeloid Leukemia Completed NCT00286845 Standard Chemotherapy
25 Barriers to Patient Enrollment Onto Frontline Therapeutic Clinical Trials and Development of Intervention Strategies to Increase the Proportion of Enrollment Completed NCT00002485
26 Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Leukaemia During Therapy With L - Asparaginase Recruiting NCT04364451

Search NIH Clinical Center for Acute Non Lymphoblastic Leukemia

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Cyclophosphamide
Etoposide
etoposide phosphate
Idarubicin
Idarubicin Hydrochloride
Mitoxantrone
Mitoxantrone Hydrochloride

Genetic Tests for Acute Non Lymphoblastic Leukemia

Anatomical Context for Acute Non Lymphoblastic Leukemia

MalaCards organs/tissues related to Acute Non Lymphoblastic Leukemia:

40
Bone, Bone Marrow, Myeloid, T Cells, Lung, Liver, Testes

Publications for Acute Non Lymphoblastic Leukemia

Articles related to Acute Non Lymphoblastic Leukemia:

(showing 262, show less)
# Title Authors PMID Year
1
Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents. 61
25284489 2015
2
Childhood cancer incidence and survival 1985-2009, Khon Kaen, Thailand. 61
25292101 2014
3
Leptin promoter G-2548A genotypes and associated serum leptin levels in childhood acute leukemia at diagnosis and under high-dose steroid therapy. 61
21955253 2012
4
[Complex chromosome damages in patients with recurrent acute leukemias after allogeneic hematopoietic stem cell transplantations]. 61
22994092 2012
5
Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. 61
22296359 2011
6
Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study. 61
20680968 2010
7
Detection of myeloperoxidase activity in primary leukemic cells by an enhanced chemiluminescent assay for differentiation between acute lymphoblastic and non-lymphoblastic leukemia. 61
19298796 2009
8
Immunoproliferative small intestinal disease versus colonic monoblastic sarcoma in a 2-year-old boy. 61
19942975 2009
9
Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. 61
18780868 2008
10
[Induced acute non-lymphoblastic leukemia and prognostic significance of cytogenetic abnormalities: trisomy in chromosome 8, inv(16)(p13q22), and t(8;21)(q22;q22)]. 61
18822849 2008
11
[MIC categorization of acute lymphoblastic leukemia with myeloid surface antigen expression]. 61
18457267 2007
12
Nitazoxanide or CD3+/CD4+ lymphocytes for recovery from severe Cryptosporidium infection after allogeneic bone marrow transplant? 61
17239134 2007
13
[Rheumatological symptoms masking neoplasm in children]. 61
18350715 2007
14
[Clinical significance of CD117/CD34 co-expression in adult patients with acute leukemia]. 61
16764777 2006
15
Spleen and lung involvement by Acinetobacter calcoaceticus bacteremia mimicking deep fungal infection in a child with acute non-lymphoblastic leukemia. 61
16078222 2006
16
[Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province]. 61
16676594 2005
17
Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north-west Italy, 1967-2001. A report of the Childhood Cancer Registry of Piedmont. 61
16154843 2005
18
Growth patterns and final height of survivors of childhood leukemia. 61
15237705 2004
19
Population-based survival after childhood cancer diagnosed during 1970-98: a report from the Childhood Cancer Registry of Piedmont, Italy. 61
12969805 2003
20
Family history of autoimmune thyroid disease and childhood acute leukemia. 61
12540505 2003
21
[Efficacy of idarubicin in the treatment of childhood acute non-lymphoblastic leukemia: report of Polish Pediatric Leukemia/Lymphoma Study Group]. 61
14575003 2003
22
Induction of a transient graft vs. leukemia effect following unrelated cord blood transplantation. 61
12234279 2002
23
Langerhans cell histiocytosis with transformation to acute leukemia showing 45,X, t(8; 21), 5q-, -Y karyotype. 61
12400613 2002
24
Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia. 61
12007019 2002
25
Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia. 61
12186694 2002
26
Consecutive IL-2 and IFN-a2a Maintenance in a Patient with Acute Non-lymphoblastic Leukemia and Renal Cell Cancer. 61
27264260 2001
27
[Invasive rhinocerebral aspergillosis occurred during myelosuppressive phase after chemotherapy: a case report and literature review]. 61
11877100 2001
28
[Ocular infiltration in the anterior chamber in a female infant with acute non-lymphoblastic leukemia]. 61
11412473 2001
29
[Apoptosis and proliferative activity of bone marrow cells in patients with aplastic syndromes as evidenced by trephine biopsy]. 61
11523410 2001
30
[Detection of hypermethylation of p15 gene in patients with acute leukemia by polymerase chain reaction]. 61
11876990 2000
31
[Childhood acute myeloblastic leukemias. Report of 21 cases]. 61
11026819 2000
32
[Importance of immunophenotyping of leukemia myelocytic acute]. 61
10770904 2000
33
[Pure red cell aplasia after allogeneic peripheral blood stem cell transplantation: a case report and literature review]. 61
11721433 1999
34
[Changes in the long arm of chromosome 3 (3q) in malignant myeloid hemopathies. A study of 10 cases]. 61
10353117 1999
35
[Immunomodulator Cycloferon in the comprehensive treatment of patients with acute non-lymphoblastic leukemia]. 61
10532100 1999
36
[Measurement of soluble Fas in patients with hematological malignancy]. 61
11938782 1999
37
Allogeneic peripheral blood stem cell transplantation in acute non-lymphoblastic leukemia. 61
10414235 1998
38
[Interstitial 9q deletion: a primary change in acute non-lymphoblastic leukemia?]. 61
9868338 1998
39
Acute non-lymphoblastic leukemia with an unusual chromosomal abnormality in a patient with advanced AIDS. 61
9792401 1998
40
[Low-dose oral etoposide and subcutaneous injection of low-dose cytosine arabinoside (Et-A non i.v.) with or without minimum anthracycline for refractory acute non-lymphoblastic leukemia]. 61
9725056 1998
41
Effect of serum from thrombocytopenic patients on platelet count in blood of mice. 61
9720349 1998
42
Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients. 61
9487372 1998
43
[Sepsis caused by Pseudomonas aeruginosa as the complication of induction treatment of acute non-lymphoblastic leukemia in a 10-year old girl]. 61
10731988 1998
44
The role of impaired transport in (pre)clinical resistance to methotrexate: insights on new antifolates. 61
17092808 1998
45
Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients. 61
9436918 1998
46
[Cytoprotective effect of amifostine in children during induction therapy according to BFM-83: report on cases]. 61
10731972 1998
47
[Secondary head and neck osteosarcoma following treatment of undifferentiated nasopharyngeal neoplasms (UCNT)]. 61
9587363 1997
48
Acute rhabdomyolysis and myonecrosis complicating aeromonas bacteremia in neutropenic patients with hematologic malignancies: report of two cases. 61
9499669 1997
49
Detection of CBFbeta/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics. 61
9180286 1997
50
Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations. 61
9096658 1997
51
Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia. 61
9594276 1997
52
Elevated levels of tissue factor pathway inhibitor in acute non-lymphoblastic leukemia patients with disseminated intravascular coagulation. 61
9105641 1997
53
[Therapeutic results in children with acute non-lymphoblastic leukemia treated with modified BFM-87 protocol]. 61
9381692 1997
54
[Successful treatment of acute non-lymphoblastic leukemia from myelodysplastic syndrome by combination of human macrophage colony-stimulating factor (M-CSF) and low dose cytosine arabinoside: M-CSF-induced proliferation and tyrosine phosphorylation in leukemic blasts]. 61
8960658 1996
55
Infections in the immunocompromised host: a prospective multicenter survey in patients receiving chemotherapy for acute leukemia. 61
9251449 1996
56
Granulocyte-macrophage-colony-stimulating factor support in patients with acute non-lymphatic leukemia. 61
8960144 1996
57
Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia. 61
8996985 1996
58
Monoblastic leukemia in an HIV-infected patient: absence of viral expression in RNA blasts. 61
8638611 1996
59
[The ANLL-NS 02 protocol for individualized therapy in acute nonlymphoblastic leukemia]. 61
9019626 1996
60
[Congenital leukemia--personal experience]. 61
8692101 1996
61
Incidence trends of acute leukemia among the children of Mexico City: 1982-1991. 61
8696068 1996
62
Molecular genetic biomarkers in hematological malignancies. 61
9027614 1996
63
Is veno-occlusive disease incidence influenced by the total-body irradiation technique? 61
8545791 1995
64
[Intense neutropenia of 14 years duration as the only manifestation of a myelodysplastic syndrome]. 61
8523943 1995
65
In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia. 61
7475276 1995
66
Fluorescent in situ hybridization for assessing the proportion of cells with trisomy 4 in a patient with acute non-lymphoblastic leukemia. 61
7668816 1995
67
Translocation (11;15)(q23;q14) in three patients with acute non-lymphoblastic leukemia (ANLL): clinical, cytogenetic and molecular studies. 61
7630191 1995
68
In vitro autonomous proliferation in ANLL: clinical and biological significance. 61
7596154 1995
69
Occurrence of acute megakaryoblastic leukemia in a patient with idiopathic growth hormone deficiency. 61
7793261 1995
70
12q13, a new recurrent breakpoint in acute non-lymphoblastic leukemia. 61
7697629 1995
71
[Granulocytic sarcoma: a study of 5 cases]. 61
7707732 1995
72
Infection in myelodysplastic syndromes before evolution into acute non-lymphoblastic leukemia. 61
7948962 1994
73
Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report. 61
8035616 1994
74
A case of polycythemia vera occurring in a patient with acute non-lymphoblastic leukemia (ANLL) in long-term first complete remission. 61
8035619 1994
75
Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias. 61
8207973 1994
76
Butyrate-induced differentiation in leukemic myeloid cells - in-vitro and in-vivo studies. 61
21567067 1994
77
Flow cytometric study of idarubicin and daunorubicin accumulation and the effect of verapamil in leukemic cell lines and fresh cells from patients with acute non-lymphoblastic leukemia. 61
8182921 1994
78
Thymidylate synthase in childhood acute non-lymphoblastic leukemia. 61
8067695 1994
79
Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemia. 61
8170171 1994
80
[Use of the NAM-protocol in the treatment of refractory acute non-lymphoblastic leukemia [M5]. 61
8026691 1994
81
Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. 61
8174068 1994
82
[Chloroma--a rare symptom of acute leukemia]. 61
7808956 1994
83
Childhood acute promyelocytic leukemia in Nicaragua. 61
8117610 1993
84
[Granulocytic sarcoma with mediastinal involvement]. 61
8060207 1993
85
Leukemia cutis. Analysis of 50 biopsy-proven cases with an emphasis on occurrence in myelodysplastic syndromes. 61
8379536 1993
86
Comparison of buffy coat preparation to direct method for the evaluation and interpretation of bone marrow aspirates. 61
8342536 1993
87
[The use of monoclonal antibodies for immunologic typing and prognosis prediction in acute non-lymphoblastic leukemia]. 61
7903627 1993
88
Mitoxantrone (dihydroxyanthracenedione) in acute leukemia. An evaluation of two treatment schedules by the Southwest Oncology Group. 61
8262731 1993
89
[The comparative evaluation of the efficacy of different therapeutic plans in acute nonlymphocytic leukemias]. 61
8211772 1993
90
Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth. 61
8429681 1993
91
[Analysis of cytoplasmic antigens in acute leukemia by flow cytometry]. 61
8450602 1993
92
Early deaths in children after BMT. Bone Marrow Transplantation Group of the Italian Association for Pediatric Hematology and Oncology (AIEOP) and Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 61
1464003 1992
93
Multidrug resistance (MDR) gene expression in acute non lymphoblastic leukemia: sequential analysis. 61
1363283 1992
94
Mitoxantrone, cytosine-arabinoside and 6-thioguanine (MAT) in the treatment of newly diagnosed acute non-lymphoblastic leukemia in adults. 61
1450441 1992
95
[Masked Philadelphia chromosome: diagnostic implications in a case of chronic myeloid leukemia presenting in blast crisis]. 61
1293781 1992
96
[Physiopathologic focus of the treatment of consumption coagulopathy in acute non-lymphoblastic leukemia]. 61
1514142 1992
97
Porphyria cutanea tarda associated with acute non-lymphoblastic leukemia. 61
1609784 1992
98
Bone marrow transplantation for acute non-lymphoblastic leukemia. 61
1472935 1992
99
Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation. 61
1617314 1992
100
High plasma urokinase-type plasminogen activator levels are present in patients with acute nonlymphoblastic leukemia. 61
1414164 1992
101
[Results and complications of induction treatment of acute leukemia in children. A personal series of 79 cases (1988-1989)]. 61
1337777 1992
102
Secondary acute non-lymphoblastic leukemia in two children following treatment with a cis-diamminedichloroplatinum-II-based regimen for osteosarcoma. 61
1727215 1992
103
[Peripheral blood stem cell autografts (PBSCT) in the treatment of 30 children with acute leukemias and lymphoma]. 61
1758049 1991
104
Oral idarubicin plus cytosine arabinoside in the treatment of acute non lymphoblastic leukemia in elderly patients. 61
1820991 1991
105
Acute non lymphoblastic leukemia in the Department of Child Health School of Medicine, University of North Sumatera/Dr. Pirngadi Hospital Medan (1983-1988), a preliminary study. 61
1780166 1991
106
[Classification of infantile acute non-lymphoblastic leukemia and prognostic correlations]. 61
1741568 1991
107
Fanconi's anemia: a clinico-hematological and cytogenetic study. 61
1802836 1991
108
Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts. 61
2059755 1991
109
[Intensification chemotherapy followed by allogenieic and autologous bone marrow transplantation in acute non-lymphoblastic leukemia in children]. 61
1853274 1991
110
[Cerebral granulocytic sarcoma disclosing acute non-lymphoblastic leukemia]. 61
2048940 1991
111
[The importance of sonography in the diagnosis of extramedullary hematopoietic foci in acute leukemia]. 61
1669197 1991
112
Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission. 61
27463208 1991
113
Proliferating cell nuclear antigen (PCNA)/cyclin expression during the cell cycle in normal and leukemic cells. 61
1683676 1991
114
Treatment of Early Stage Hodgkin's Disease According to Risk Factors. 61
27462944 1991
115
N-ras gene mutations in childhood acute non-lymphoblastic leukemia. 61
1921453 1991
116
A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia. 61
27467426 1991
117
Ambiguous patterns in cellular differentiation in a case of "M3 variant" leukemia. 61
1820773 1991
118
Epidural Spinal Cord Infiltration: A Rare Complication of Acute Myeloblastic Leukaemia. 61
27462946 1991
119
Monitoring the unmaintained remission of acute non-lymphoblastic leukemia by serial bone marrow cultures. 61
1861533 1991
120
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission. 61
2097012 1990
121
P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia. 61
1982999 1990
122
Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. 61
2211256 1990
123
Cancer procoagulant in acute lymphoblastic leukemia. 61
2209822 1990
124
[Acute mixed-cell human leukemia]. 61
2253855 1990
125
[Monoclonal antibodies ICO-11 in the prognostic evaluation of acute nonlymphoblastic leukemia]. 61
2253864 1990
126
Purged autologous bone marrow transplantation in the treatment of acute leukemia. 61
2145009 1990
127
Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients. 61
2202469 1990
128
Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitors. 61
2115009 1990
129
Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. 61
2350628 1990
130
[Treatment of acute non-lymphoblastic leukemia in adults. Preliminary report from the national protocol on antineoplastic drugs]. 61
2133162 1990
131
Ras gene product expression in blood and marrow smears of patients with acute leukemia: importance of fixation. 61
2235101 1990
132
Allogenic versus autologous marrow transplantation for patients with acute non lymphoblastic leukemia in first complete remission. 61
2358214 1990
133
Karyotypic changes identified by HaeIII restriction endonuclease banding in a patient with M2 acute non-lymphoblastic leukemia. 61
2278962 1990
134
[Treatment results of bone marrow transplantation in Kyushu Cancer Center. Bone Marrow Transplantation Team]. 61
2366334 1990
135
[Granulocytic sarcoma (chloroma): rare extramedullary tumors associated with acute non-lymphoblastic leukemia]. 61
2163510 1990
136
Acute Nonlymphoblastic Leukemia: Treatment of Elderly Patients. 61
27456741 1990
137
Breakpoints Involved in Deletions of the Long Arm of Chromosome 5 in Myelodysplasia and Acute Non-Lymphoblastic Leukemia do not Correlate with the Morphological Diagnosis. 61
27457437 1990
138
Epirubicin in Childhood Acute Lymphoblastic and Myeloid Leukemia in Relapse. 61
27463987 1990
139
Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients). 61
2099400 1990
140
[Characteristics of chromosomal and mitotic disorders in patients with acute non-lymphoblastic leukemia exposed to chemical factors]. 61
2328900 1990
141
Recent trends in allogeneic bone marrow transplantation. 61
2257566 1990
142
Cytosine arabinoside does not cause differentiation in vitro of CFU-GM in marrow from normal, myelodysplastic or ANLL subjects. 61
2314114 1990
143
Acute non-lymphoblastic leukemia in children: prognostic factors and results of chemotherapy. 61
2361737 1990
144
A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic Leukemia. 61
27456922 1990
145
Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia. 61
2479459 1989
146
Granulocyte colony-stimulating factor in allogeneic bone marrow transplantation. 61
2481758 1989
147
New conditioning regimens for high risk marrow transplants. 61
2627618 1989
148
In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations. 61
2482193 1989
149
A comparison of two assays for the in vitro chemosensitivity testing of human acute non-lymphoblastic leukemia cells. 61
2585033 1989
150
Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557). 61
2653856 1989
151
Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. 61
2671466 1989
152
[Frequency and severity of systemic infections caused by Streptococcus mitis and sanguis II in neutropenic children]. 61
2780102 1989
153
Ten-year nodular sclerosis Hodgkin's disease and second malignancies. 61
2714343 1989
154
[Release of peripheral blood stem cells following chemotherapy in childhood malignancies]. 61
2671433 1989
155
Prevention of leukemic relapse after transplantation with lymphocyte depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclines. 61
2650787 1989
156
Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results. 61
2654791 1989
157
Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia. 61
2912519 1989
158
[Low doses of cytarabine in the treatment of acute non-lymphoblastic leukemia in adults]. 61
2721906 1989
159
Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse. 61
2653513 1989
160
Colony formation of CFU-MK and other hemopoietic progenitors in patients with acute non-lymphoblastic leukemia at diagnosis and following complete remission. 61
2616265 1989
161
[Treatment of patients with acute nonlymphoblastic leukemia with low doses of cytarabine]. 61
2721900 1989
162
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. 61
2653485 1989
163
Clinical value of long-term maintenance chemotherapy in 5-year survivors of acute leukemia. 61
2586145 1989
164
Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia. 61
2647183 1989
165
[Characteristics of the silver-stained nucleoli in blast elements of various diameters from patients with acute leukemia]. 61
2470179 1988
166
Improvement in the treatment of childhood cancer: analysis of survival data from the National Children's Hospital (1965-1987). 61
2849693 1988
167
Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission. 61
3063322 1988
168
[Surface marker analysis in childhood acute non-lymphoblastic leukemia. Children's Cancer and Leukemia Study group]. 61
3070075 1988
169
Intensive chemotherapy for acute non-lymphoblastic leukemia after primary myelodysplastic syndrome. 61
3181878 1988
170
Spontaneous complete remission in acute non-lymphoblastic leukemia. 61
3224987 1988
171
Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remission. 61
3291991 1988
172
Peplomycin. DNA breakage and in vivo inhibition of DNA polymerases and ligase from human normal and leukemic cells. 61
2453304 1988
173
Iron-binding reactivity in mature neutrophils: relative cell content quantification by cytochemical scoring. 61
3367050 1988
174
Effects of verapamil on uptake and in vitro toxicity of anthracyclines in human leukemic blast cells. 61
3163975 1988
175
Repeated courses of high dose melphalan and unpurged autologous bone marrow transplantation in children with acute non-lymphoblastic leukemia in first complete remission. 61
3048474 1988
176
[Leukemia in childhood]. 61
3050901 1988
177
Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. 61
2894085 1988
178
[The value of chromosome anomalies in the prognosis of acute non-lymphoblastic leukemia in children]. 61
3387201 1988
179
Autologous bone marrow transplantation in children. 61
3064935 1988
180
Long-term survival of children with acute non-lymphoblastic leukemia. 61
3419391 1988
181
Recent advances in bone marrow transplantation. 61
3325011 1987
182
Idarubicin in combination with etoposide and cytarabine in adult untreated acute non lymphoblastic leukemia. 61
3480803 1987
183
The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. 61
3332174 1987
184
Acute non-lymphoblastic leukemia. Correlation between clinical and hematological parameters in 87 adult patients. 61
3121464 1987
185
[Acute non-lymphoblastic leukemia developing soon after small cell lung carcinoma]. 61
2819844 1987
186
Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia. 61
3478198 1987
187
[Analysis of prognostic factors and predictive models of response to induction chemotherapy in acute non-lymphoblastic leukemia]. 61
3626658 1987
188
Intracytoplasmic inclusions in acute non-lymphoblastic leukemia. An ultrastructural study. 61
3451022 1987
189
[Prognosis in acute non-lymphoblastic leukemia]. 61
3306191 1987
190
Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557). 61
3332155 1987
191
Maintenance of myeloid leukemic cells in the adherent layers of long-term bone marrow cultures. 61
3470534 1987
192
[Intensive polychemotherapy in the treatment of acute non-lymphoblastic leukemia: comparison of the prospective protocols DATOP/79 and DATOP/82]. 61
3561058 1987
193
[Autograft of bone marrow treated by in vitro chemotherapy (Asta Z 7557) for consolidation of acute leukemia in adults in the first complete remission]. 61
2950482 1987
194
Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin. 61
3295628 1987
195
[Importance of anthracyclines in infants in the treatment of acute lymphoblastic and non-lymphoblastic leukemias]. 61
3550617 1987
196
[Plasma fibronectin in acute leukemia. Effects of the cytostatic therapy on plasma fibronectin level]. 61
2444508 1987
197
[Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification]. 61
3468610 1987
198
[Variants of acute non-lymphoblastic leukemia in children]. 61
3479746 1987
199
[High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia]. 61
3660187 1987
200
[Development and validation of models for predicting the response to intensive induction chemotherapy in acute non-lymphoblastic leukemia]. 61
3424049 1987
201
[Differentiation of human malignant myeloid and lymphoid cells]. 61
2438644 1987
202
Residual leukemia cannot be detected in very early remission peripheral blood stem cell collections in acute non-lymphoblastic leukemia. 61
3561018 1987
203
Treatment of adult acute non-lymphoblastic leukemia: a computer-aided analysis. 61
3108100 1987
204
[Importance of changes in potassium in the management of patients with acute non-lymphoblastic leukemia]. 61
3807453 1986
205
[Cases of adult acute non-lymphoblastic leukemia in patients disease-free for more than 2 years]. 61
3547238 1986
206
A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. 61
3537219 1986
207
[Allogeneic bone marrow transplantation in the treatment of acute leukemias of children. Study of 26 patients]. 61
3548633 1986
208
[Acute non-lymphoblastic leukemia with Burkitt-type morphology in a patient with psoriatic arthropathy treated with immunosuppressors]. 61
3463838 1986
209
The impact of leukemia status at the time of HLA-identical sibling marrow transplantation on subsequent complication rate and survival of adults with acute leukemia. 61
3541875 1986
210
Phorbol ester (TPA)-induced surface membrane alterations in B-type hairy cell and lymphocytic leukemia cells. 61
3810025 1986
211
Clinical significance of human bone marrow stromal cell colonies in acute leukemias. 61
3796036 1986
212
[Calculation of direct standard costs in the evaluation of new technologies: application to the treatment of acute myeloblastic leukemias]. 61
3088684 1986
213
[Reproducibility of the FAB classification and prognostic value of the principle cytologic characteristics in 147 cases of acute non-lymphoblastic leukemia]. 61
3787414 1986
214
Distribution and content of nuclear and cellular RNA among cell populations of acute lymphoblastic and nonlymphoblastic leukemia. 61
3861243 1985
215
Low dose cytarabine in acute non-lymphoblastic leukemia or myelodysplastic syndrome: report of six cases and review of the literature. 61
3859258 1985
216
Prognostic significance of primary bone changes in children with acute lymphoblastic leukemia. 61
3858786 1985
217
Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL). 61
2408974 1985
218
Successful treatment of acute non-lymphoblastic leukemia in a state-supported hospital. 61
6512523 1984
219
[Acute non-lymphoblastic leukemia in children. Therapeutic results apropos of 52 cases]. 61
6596906 1984
220
[Acute non-lymphoblastic leukemia presenting the Philadelphia chromosome and chromosome 7 monosomy]. 61
6522697 1984
221
[Advances in the treatment of acute non-lymphoblastic leukemia in adults]. 61
6384971 1984
222
Concanavalin A receptors on the surface membrane of lymphocytes from patients with acute leukemia. 61
6471903 1984
223
Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemia. 61
6595242 1984
224
[Prognostic factors and new drugs in acute non-lymphoblastic leukemia]. 61
6681391 1983
225
[Acute non-lymphoblastic leukemia in patients treated for Hodgkin's disease. Analysis of 309 cases]. 61
6580555 1983
226
Treatment of early stage Hodgkin's disease with radiation therapy plus short-cycle (3 MOPP) adjuvant chemotherapy. 61
6689093 1983
227
[Granulocytic sarcoma in acute non-lymphoblastic leukemia as the terminal phase of multiple myeloma under prolonged treatment with alkylating agents]. 61
6416948 1983
228
[Bone marrow cell culture of acute non-lymphoblastic leukemia (ANLL) and its relation to prognosis]. 61
6641384 1983
229
[Hematologic and cytogenetic study of 7 cases of preleukemic state or acute leukemia following the treatment of a first malignancy]. 61
6308798 1983
230
Acute non-lymphoblastic leukemia after treatment of nodular lymphoma with human leukocyte interferon. 61
6340577 1983
231
[Preleukemia]. 61
6594995 1983
232
[Lesions evoking Sweet's syndrome in acute leukemia: occurring during the stage of therapeutic aplasia]. 61
6574722 1983
233
Increased mortality by septicemia, interstitial pneumonitis and pulmonary fibrosis among bone marrow transplant recipients receiving an increased mean dose rate of total irradiation. 61
6328871 1983
234
Allogeneic bone marrow transplantation. 61
6373140 1983
235
Effect of neuraminidase treatment on serum reactivity to autologous leukemic blast cells. 61
6193868 1983
236
[Diagnosis of acute leukemia in childhood]. 61
6984132 1982
237
[Factors determining the prognosis of leukemia]. 61
7167958 1982
238
[Two cases of acute non-lymphoblastic leukemia treated with allogeneic bone marrow transplantation]. 61
6290710 1982
239
Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission. 61
6750252 1982
240
Allogeneic marrow transplantation for acute leukemia in relapse. 61
6750250 1982
241
Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation. 61
6750251 1982
242
Sialyltransferase activity in leukemia. 61
7186087 1982
243
Intravenous vincristine infusion: phase I trial. 61
7306914 1981
244
[Preleukemic states]. 61
7280630 1981
245
An attempt to obtain a specific antiserum for in vitro immunological conditioning of bone marrow in acute non-lymphoblastic leukemia. 61
6974887 1981
246
Androgen, estrogen and progestin binding sites in human leukemic cells. 61
6945298 1981
247
[Implications of terminal deoxynucleotidyl transferase activity in various forms of childhood leukemia (author's transl)]. 61
6943391 1981
248
Bone marrow transplantation for aplastic anemia and acute leukemia at Huddinge Hospital. 61
6755685 1981
249
Pharmacokinetics of daunorubicin after administration as free drug or as DNA complex in leukemic patients. 61
7261253 1981
250
Selective use of daunorubicin for remission-induction chemotherapy in acute non-lymphoblastic leukemia. 61
6932996 1980
251
[Combined chemotherapy: prednisone, cytosine arabinose and vincristine in the treatment of acute non-lymphoblastic leukemia in the adult]. 61
7002697 1980
252
The labelling index of marrow myeloblasts: a predictive test for relapse of acute non-lymphoblastic leukemia. 61
6931957 1980
253
Comparison of plasma deoxyribonuclease activity between normal and leukemic states in man and mice. 61
526535 1979
254
[Relations between chromosomal findings and prognosis in acute nonlymphoblastic leukemia (author's transl)]. 61
444677 1979
255
Acute leukemia following prolonged cytotoxic agent therapy. 61
105227 1979
256
Acute non-lymphoblastic leukemia. 61
280458 1978
257
[Therapeutic results in adult acute non-lymphoblastic leukemia]. 61
742015 1978
258
[Trial of androgen therapy in the treatment of acute non-lymphoblastic leukemia in children. Initial results]. 61
273201 1978
259
Prognostic value of colony-stimulating and colony-forming cells in peripheral blood in acute non-lymphoblastic leukemia. 61
302633 1977
260
Treatment of adult acute non-lymphoblastic leukemia using intermittent combination chemotherapy with daunomycin, cytosine arabinoside, 6-mercaptopurine and prednisolone-DCMP two step therapy. 61
1067159 1976
261
[Androgens and prolonged complete remissions in acute non lymphoblastic leukemias. Results of a systematic treatment with stanozolol associated with chemotherapy (author's transl)]. 61
126425 1975
262
Daunorubicin-DNA: further clinical trials in acute non-lymphoblastic leukemia. 61
4469493 1974

Variations for Acute Non Lymphoblastic Leukemia

Expression for Acute Non Lymphoblastic Leukemia

Search GEO for disease gene expression data for Acute Non Lymphoblastic Leukemia.

Pathways for Acute Non Lymphoblastic Leukemia

GO Terms for Acute Non Lymphoblastic Leukemia

Sources for Acute Non Lymphoblastic Leukemia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....